Arteriosclerosis
Not yet recruitingStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
- Disease:Arteriosclerosis
- Substances:–
Denmark- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Denmark49 clinical trials in Viborg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focused on heart failure prevention and treatment of acute coronary syndromes. Studies evaluating novel therapies for reducing cardiovascular events and managing atherosclerotic disease.
Multiple investigations exploring innovative approaches to prevent stroke and manage cardiovascular complications.
Clinical research examining treatments for acute interstitial nephritis and evaluating new approaches for patients requiring hemodialysis care.
Focus on improving outcomes for patients with various forms of kidney disease and related conditions.
Advanced research into multiple sclerosis treatments and migraine management, including both preventive and acute therapeutic approaches.
Innovative trials comparing established and novel treatments for neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.